3 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 3, Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Weight Management: new trials by email Literature Review of Weight Management trials Research Report on Weight Management
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity ecnoglutide tablet, placebo with matching dosage - Overweight , Obesity, Weight Management | Phase 2 | Not yet recruiting | Hangzhou Sciwind Biosciences Co., Ltd. | 180 | 2026-11-10 | 2026-11-10 |
| MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial ECC4703, Placebo, Semaglutide - Adult Obesity, Weight Management | Phase 2 | Active not recruiting | Eccogene | 151 | 2026-03-23 | 2026-06-25 |
| A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity ecnoglutide tablets, placebo with matching dosage - Overweight and/or Obesity, Weight Management | Phase 1 / Phase 2 | Recruiting | Hangzhou Sciwind Biosciences Co., Ltd. | 126 | 2025-11-18 | 2026-09-16 |
| A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) XW003 injection, semaglutide injection - Obesity, Weight Management | Phase 2 | Active not recruiting | Hangzhou Sciwind Biosciences Co., Ltd. | 163 | 2025-07-28 | 2026-04-13 |
| GV101 in Healthy Obese Participants GV101, GV101 placebo - Weight Management | Phase 2 | Completed | Graviton Bioscience Corporation | 131 | 2025-06-30 | 2026-02-04 |
| A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea HRS9531 Injection, Placebo Injection - Weight Management | Phase 2 | Unknown | Fujian Shengdi Pharmaceutical Co., Ltd. | 108 | 2024-08-01 | 2024-08-22 |
| A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight CE-326,597 100 mg QD, CE-326,597 50 mg QD, CE-326,597 25 mg QD - Weight Management, Treatment Of Obesity | Phase 2 | Completed | Pfizer | 252 | 2007-12-01 | 2012-11-07 |
| Effects of Protein-Enriched Meal on Liver, Kidney or Bone: a Randomized Controlled Trial Herbalife Meal Replacements - Weight Reduction, Obesity | Phase 2 / Phase 3 | Completed | University of California, Los Angeles | 100 | 2004-07-01 | 2025-05-25 |
Obesity (5) · Overweight (2) · Weight Loss (1)
Body Weight (5) · Nutrition Disorders (5) · Nutritional and Metabolic Diseases (5) · Overnutrition (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Overweight (3) · Body Weight Changes (1)
semaglutide (2)
Hangzhou Sciwind Biosciences Co., Ltd. (3) · Eccogene (1) · Fujian Shengdi Pharmaceutical Co., Ltd. (1) · Graviton Bioscience Corporation (1) · Pfizer (1) · University of California, Los Angeles (1)
United States (4) · China (3) · Bulgaria (1) · Canada (1) · India (1) · Israel (1) · Mexico (1) · Puerto Rico (1) · Spain (1)
Hongwei Jiang (1) · Jintong Li, Dr (1) · Linong Ji, Dr (1) · Zhaoping Li, MD, PhD (1)